These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 15809742

  • 1. Oncostatin M signaling in human glioma cell lines.
    Krona A, Järnum S, Salford LG, Widegren B, Aman P.
    Oncol Rep; 2005 May; 13(5):807-11. PubMed ID: 15809742
    [Abstract] [Full Text] [Related]

  • 2. Coexpression of oncostatin M and its receptors and evidence for STAT3 activation in human ovarian carcinomas.
    Savarese TM, Campbell CL, McQuain C, Mitchell K, Guardiani R, Quesenberry PJ, Nelson BE.
    Cytokine; 2002 Mar 21; 17(6):324-34. PubMed ID: 12061840
    [Abstract] [Full Text] [Related]

  • 3. Oncostatin M induces an acute phase response but does not modulate the growth or maturation-status of liver progenitor (oval) cells in culture.
    Matthews VB, Knight B, Tirnitz-Parker JE, Boon J, Olynyk JK, Yeoh GC.
    Exp Cell Res; 2005 May 15; 306(1):252-63. PubMed ID: 15878349
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Divergent effects of oncostatin M on astroglioma cells: influence on cell proliferation, invasion, and expression of matrix metalloproteinases.
    Chen SH, Gillespie GY, Benveniste EN.
    Glia; 2006 Jan 15; 53(2):191-200. PubMed ID: 16206166
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
    Royuela M, Ricote M, Parsons MS, García-Tuñón I, Paniagua R, de Miguel MP.
    J Pathol; 2004 Jan 15; 202(1):41-9. PubMed ID: 14694520
    [Abstract] [Full Text] [Related]

  • 8. Oncostatin-M induction of vascular endothelial growth factor expression in astroglioma cells.
    Repovic P, Fears CY, Gladson CL, Benveniste EN.
    Oncogene; 2003 Nov 06; 22(50):8117-24. PubMed ID: 14603252
    [Abstract] [Full Text] [Related]

  • 9. Oncostatin M (OSM) cytostasis of breast tumor cells: characterization of an OSM receptor beta-specific kernel.
    Underhill-Day N, Heath JK.
    Cancer Res; 2006 Nov 15; 66(22):10891-901. PubMed ID: 17108126
    [Abstract] [Full Text] [Related]

  • 10. Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue.
    Rega G, Kaun C, Weiss TW, Demyanets S, Zorn G, Kastl SP, Steiner S, Seidinger D, Kopp CW, Frey M, Roehle R, Maurer G, Huber K, Wojta J.
    Circulation; 2005 Apr 19; 111(15):1938-45. PubMed ID: 15837947
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sodium butyrate sensitizes human glioma cells to TRAIL-mediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP.
    Kim EH, Kim HS, Kim SU, Noh EJ, Lee JS, Choi KS.
    Oncogene; 2005 Oct 20; 24(46):6877-89. PubMed ID: 16007142
    [Abstract] [Full Text] [Related]

  • 13. GP130/OSMR is the only LIF/IL-6 family receptor complex to promote osteoblast differentiation of calvaria progenitors.
    Malaval L, Liu F, Vernallis AB, Aubin JE.
    J Cell Physiol; 2005 Aug 20; 204(2):585-93. PubMed ID: 15751050
    [Abstract] [Full Text] [Related]

  • 14. Oncostatin M, a multifunctional cytokine.
    Tanaka M, Miyajima A.
    Rev Physiol Biochem Pharmacol; 2003 Aug 20; 149():39-52. PubMed ID: 12811586
    [Abstract] [Full Text] [Related]

  • 15. Expression of oncostatin M and its receptors in normal and cirrhotic human liver.
    Znoyko I, Sohara N, Spicer SS, Trojanowska M, Reuben A.
    J Hepatol; 2005 Nov 20; 43(5):893-900. PubMed ID: 16169119
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Loss of oncostatin M receptor beta in metastatic melanoma cells.
    Lacreusette A, Nguyen JM, Pandolfino MC, Khammari A, Dreno B, Jacques Y, Godard A, Blanchard F.
    Oncogene; 2007 Feb 08; 26(6):881-92. PubMed ID: 16909117
    [Abstract] [Full Text] [Related]

  • 18. The gp130 ligand oncostatin M regulates tissue inhibitor of metalloproteinases-1 through ERK1/2 and p38 in human adult cardiac myocytes and in human adult cardiac fibroblasts: a possible role for the gp130/gp130 ligand system in the modulation of extracellular matrix degradation in the human heart.
    Weiss TW, Kvakan H, Kaun C, Zorn G, Speidl WS, Pfaffenberger S, Maurer G, Huber K, Wojta J.
    J Mol Cell Cardiol; 2005 Sep 08; 39(3):545-51. PubMed ID: 15890357
    [Abstract] [Full Text] [Related]

  • 19. Significant inhibition of TRAIL-mediated fibroblast-like synovial cell apoptosis by IFN-gamma through JAK/STAT pathway by translational regulation.
    Tamai M, Kawakami A, Tanaka F, Miyashita T, Nakamura H, Iwanaga N, Izumi Y, Arima K, Aratake K, Huang M, Kamachi M, Ida H, Origuchi T, Eguchi K.
    J Lab Clin Med; 2006 Apr 08; 147(4):182-90. PubMed ID: 16581346
    [Abstract] [Full Text] [Related]

  • 20. Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas.
    Kumamoto H, Ooya K.
    J Oral Pathol Med; 2005 May 08; 34(5):287-94. PubMed ID: 15817072
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.